China Pharma Holdings, Inc. Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall Street ends higher as tech rebounds before Nvidia results
- Oil settles down more than 3%; investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wall Street ends higher as tech rebounds before Nvidia results
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism'
- Dick's Sporting Goods (DKS) Misses Q2 EPS by 25c, Offers Guidance
China Pharma Holdings, Inc. (CPHI) Reports Q2 Loss of $0.02/share
August 15, 2018 6:26 AM EDTChina Pharma Holdings, Inc. (NYSE: CPHI) reported Q2 EPS of ($0.02), versus ($0.05) reported last year. Revenue for the quarter came in at $3.2 million, versus $3 million reported last year.
For earnings history and earnings-related data on China Pharma Holdings, Inc. (CPHI) click here.
... More